16^th World Hematology Congress

Allogeneic hematopoietic stem cell transplantation (HSCT) has become an established therapy in the treatment of patients with a range of hematological and non-hematological disorders. The number of allogeneic stem cell transplants increases every year. The risks and options for the stem cell recipients are well defined and documented and transplant physicians are well aware of the procedures in their facility. Physiological and psychological factors for the recipient are part of the daily routine. In contrast to the situation for the recipients, hematopoietic stem cell donation is often considered a relatively safe procedure for the donor and the physiological and psychological impact on the donor is not the focus of the transplant physician. When donors are included in studies and become research objects the process gets even more complicated. The knowledge and understanding about the obstacles and challenges of all the parties involved in stem cell donation are fundamental for the success of the allogeneic hematopoietic stem cell transplantation. We believe it is necessary to create an understanding in the clinical community and the impact of the stem cell donation has on the donors and how important the exchange of information is with regard to preserving donor commitment and availability.